Science Explorer Interactive view Map
Company · Winchester · United Kingdom

Biopharma Technology (United Kingdom)

biopharma.co.ukROR OpenAlex
Research works
63
▼ 24% vs 2013–17
Citations
465
7.4 per fractional work
Top-10% rate
12.7%
record average 16.5%
Open access
53%
world 28%

Not ranked overall: Biopharma Technology (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.16× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.46× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 4.67× its world share, 1 worksImmunology and Micro…Neuroscience: 2.77× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.69× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 2.54× its world share, 0 worksChemical EngineeringChemistry: 1.44× its world share, 0 worksChemistryComputer Science: 0.39× its world share, 1 worksComputer ScienceEnergy: 0.96× its world share, 0 worksEnergyEngineering: 0.30× its world share, 1 worksEngineeringEnvironmental Science: 0.27× its world share, 0 worksEnvironmental ScienceMathematics: 0.30× its world share, 0 worksMathematicsMedicine: 2.10× its world share, 8 worksMedicineDecision Sciences: 0.61× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.66× its world share, 1 worksEconomics, Econometr…Psychology: 0.29× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.7×. Every wedge is a field page.

Which keywords describe research at Biopharma Technology (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Pharmaceutical Industry, Drug Development Costs, Generic Drugs, Monoclonal Antibodies and Therapeutic Antibodies.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 39 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 39 words, with their numbers
  1. Quality of Life7▲ 8.3×4 topics
  2. Cost-effectiveness Analysis7▲ 138×1 topic
  3. Health Utility Measures7▲ 138×1 topic
  4. Pharmaceutical Industry5▲ 200×2 topics
  5. Drug Development Costs4▲ 276×1 topic
  6. Generic Drugs4▲ 276×1 topic
  7. Monoclonal Antibodies3▲ 35×3 topics
  8. Therapeutic Antibodies3▲ 35×2 topics
  9. Clinical Trials3▲ 6.8×7 topics
  10. Inflammation3▲ 1.79×17 topics
  11. Cancer2▲ 2.8×16 topics
  12. Glycosylation2▲ 16×3 topics
  13. Immunogenicity2▲ 71×3 topics
  14. Protein Aggregation2▲ 44×2 topics
  15. Biopharmaceuticals2▲ 50×3 topics
  16. Drug Development2▲ 21×4 topics
  17. Recombinant Proteins2▲ 53×2 topics
  18. Chromatography2▲ 89×1 topic
  19. Primary Care2▲ 6.2×4 topics
  20. Stability2▲ 13×1 topic
  21. Epidemiology2▼ 0.61×14 topics
  22. Oxidative Stress2▲ 1.29×13 topics
  23. Machine Learning1◆ 1.04×5 topics
  24. Immunotherapy1▲ 3.1×5 topics
  25. Lymphoma1▲ 14×3 topics
  26. Antibody Engineering1▲ 19×1 topic
  27. Fc Receptors1▲ 19×1 topic
  28. Innovation1▲ 2.2×5 topics
  29. Nanoparticles1▲ 1.39×5 topics
  30. Public Health1▲ 1.37×3 topics
  31. Adverse Drug Reactions1▲ 28×3 topics
  32. Cancer Immunotherapy1▲ 13×2 topics
  33. Genome Engineering1▲ 31×1 topic
  34. Leukemia1▲ 27×2 topics
  35. RNA-Guided1▲ 31×1 topic
  36. Fuzzy Controller1▲ 74×1 topic
  37. Mitochondrial Dysfunction1▲ 4.5×4 topics
  38. Redundant Transmission1▲ 74×1 topic
  39. Risk Factors1▲ 1.53×6 topics

Which research topics does Biopharma Technology (United Kingdom) publish most on?

By volume in 2022–2025: CRISPR and Genetic Engineering, Monoclonal and Polyclonal Antibodies Research, Cancer-related molecular mechanisms research and Genetic Neurodegenerative Diseases.

CRISPR and Genetic Engineering: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksCancer-related molecular…1Cancer-related molecular mechanisms research: 1 fractional worksGenetic Neurodegenerativ…1Genetic Neurodegenerative Diseases: 1 fractional worksBiosensors and Analytical Detection: 0 fractional worksCOVID-19 diagnosis using AI: 0 fractional worksPharmaceutical Economics…0Pharmaceutical Economics and Policy: 0 fractional worksDrug-Induced Adverse Reactions: 0 fractional worksScience, Research, and Medicine: 0 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional works
Molecular BiologyRadiology, Nuclear Medicine and ImagingCancer ResearchCellular and Molecular Neuroscience4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CRISPR and Genetic Engineering Molecular Biology 1 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  3. 3 Cancer-related molecular mechanisms research Cancer Research 1 works
  4. 4 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 1 works
  5. 5 Biosensors and Analytical Detection Biomedical Engineering 0 works
  6. 6 COVID-19 diagnosis using AI Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
  8. 8 Drug-Induced Adverse Reactions Pharmacology 0 works
  9. 9 Science, Research, and Medicine Reproductive Medicine 0 works
  10. 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.8%not open47.2%

World: 28% of research is openly available.

with international co-authors41.0%domestic only59.0%

World: 19% is written across borders.

How has Biopharma Technology (United Kingdom)'s research output changed?

Output in 2018–2022 was 24% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Winchester

All research institutions in Winchester

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.